Big Boss Talk

EN

If you are interested in tissue engineering and biomaterials or if you simply want to know how we can save lives in the future, this event is for you!

On May 7th at 6:30 p.m., Professor Alexander M. Seifalien will join us at IST to talk about one of the most promising areas of science currently: “How to Create and develop human organs in laboratory for transplant: present and (near) future.”

This speaker is a renowned researcher in the Department of Surgery and Interventional Sciences at University College London.

Prof. Seifalien has a very diverse research work and his main areas of interest are the development of nanomaterials and stem cells that can replace human organs; the development of nanofluorescent particles for the treatment of cancer, among others.

Don’t miss it!

Sign Up here!

PT

Se te interessas por engenharia de tecidos e biomateriais ou se simplesmente queres saber como no futuro poderemos salvar vidas, este evento é para ti!

No dia 7 de Maio às 18h30, o Professor Alexander M. Seifalien juntar-se-á a nós no IST para nos falar sobre um dos temas mais promissores da atualidade científica:"How to Create and develop human organs in laboratory for transplant: present and (near) future".

Este orador é um investigador de renome do departamento de Cirurgia e Ciências Intervencionais da University College London.

Tem um trabalho de investigação muito diverso, sendo as suas principais áreas de interesse o desenvolvimento de nanomateriais e células estaminais que possam substituir órgãos humanos; o desenvolvimento de partículas nanofluorescentes para o tratamento de cancro, entre outras.

Aparece!

Inscreve-te aqui!

EN

Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a period of time at Harvard Medical School looking at caused of cardiovascular diseases and a year at Johns Hopkins Medical School looking at treatment of liver. He published more than 647 peer-reviewed research papers, and registered 14 UK and International patents. He is currently CEO of NanoRegMed Ltd, working on the commercialisation of his research. During his career Prof Seifalian has led and managed many large projects with successful outcomes in terms of commercialisation and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards’ Winner of Most Innovative New Product 2012 for the “synthetic trachea”. Prof Seifalian won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include development of the world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. He has over 15,000 media report from his achievement, include BBC, ITV, WSJ, CNN, and many more. Currently he is working on development and commercialisation of human organs using graphene based nanocomposite materials and stem cells technology.

PT

Alexander Seifalian, Professor de Nanotecnologia e Medicina Regenerativa, trabalhou o Royal Free Hospital and University College em Londres por mais de 26 anos. Durante este tempo, passou uma temporada na Harvard Medical School à procura da causa de doenças cardiovasculares e um ano no Johns Hopkins Medical School observando tratamentos ao fígado. Publicou mais de 647 peer-reviewed research papers e registou 14 patentes no UK e internacionais. É atualmente o CEO da NanoRegMed Ltd, trabalhando na comercialização da sua pesquisa. Durante a sua carreira, Prof Seifalian liderou e geriu vários projetos de grande dimensão com outcomes de sucesso em termos de comercialização e translação para patentes. Em 2007 foi galhardeado com o prémio principal no campo do desenvolvimento de nano materiais e tecnologias para implantes cardiovasculares pela Medical Future Innovation e, em 2009, recebeu um Business Innovation Award do UK Trade & Investment (UKTI). Foi o European Life Science Awards’ Winner of Most Innovative New Product 2012 com uma “traqueia sintética”. Ganhou o Nanosmat Prize em 2013 e, em 2016, recebeu o Distiguish Research Award como reconhecimento do seu trabalho tremendo em medicina regenerativa da Heals Healthy Life Extension Society. As suas conquistas incluem o desenvolvimento da primeira traqueia sintética, um condutor de drenagem lacrimal e um enxerto para bypass vascular usando materiais de nano compósitos, moléculas bioativas e tecnologia de células estaminais. Tem mais de 15,000 artigos nos media destas conquistas, incluindo BBC, ITV, WSJ, CNN, e muitos outros. Atualmente está a trabalhar no desenvolvimento e comercialização de órgãos humanos usando materiais de nano compósitos baseados em grafeno e tecnologias de células estaminais.



Com o apoio de: